Rational engineering in Escherichia coli for high-titer production of baicalein based on genome-scale target identification.

Abstract

Baicalein is a bioactive flavonoid isolated from the traditional Chinese medicinal plant, Scutellaria baicalensis Georgi. Microbial synthesis of flavonoids has been intensively developed owing to the eco-friendly nature of the process. However, the titer of the flavonoids obtained is still at a low level, and effective methods to enhance these titers are lacking. In this study, the synthetic performance of baicalein-producing engineered Escherichia coli was rationally evaluated to enhance the expression of key enzymes. Transcriptional analyses of baicalein-overproducing strain and a control strain enabled the identification of 13 beneficial genes, including eight genes that are seemingly irrelevant to baicalein metabolism. With the combination of the enzyme assembly and modularization strategy, the engineered DN-8 strain produced 367.8 mg/L baicalein in fed-batch fermentation, the maximum titer reported to date.